MediWound (MDWD) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

MDWD Stock Forecast

MediWound stock forecast is as follows: an average price target of $28.00 (represents a 69.80% upside from MDWD’s last price of $16.49) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.

MDWD Price Target

The average price target for MediWound (MDWD) is $28.00 based on 1-year price targets from 4 Wall Street analysts in the past 3 months, with a price target range of $28.00 to $28.00. This represents a potential 69.80% upside from MDWD's last price of $16.49.

MDWD Analyst Ratings

Buy

According to 4 Wall Street analysts, MediWound's rating consensus is 'Buy'. The analyst rating breakdown for MDWD stock is 0 'Strong Buy' (0.00%), 4 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

MediWound Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Oct 11, 2024	Swayampakula Ramakanth	H.C. Wainwright	$28.00	$16.92	65.48%	69.80%
May 29, 2024	Francois Brisebois	Oppenheimer	$36.00	$16.01	124.86%	118.31%
Jan 04, 2023		H.C. Wainwright	$23.00	$13.29	73.06%	39.48%
Dec 30, 2022		Cowen & Co.	$25.00	$13.49	85.32%	51.61%
Dec 22, 2022		Maxim Group	$25.00	$11.01	127.07%	51.61%
Nov 16, 2022		H.C. Wainwright	$0.79	$0.24	229.34%	-95.24%

The latest MediWound stock forecast, released on Oct 11, 2024 by Swayampakula Ramakanth from H.C. Wainwright, set a price target of $28.00, which represents a 65.48% increase from the stock price at the time of the forecast ($16.92), and a 69.80% increase from MDWD last price ($16.49).

MediWound Price Target by Period

	1M	3M	12M
# Anlaysts	-	1	2
Avg Price Target	-	$28.00	$32.00
Last Closing Price	$16.49	$16.49	$16.49
Upside/Downside	-100.00%	69.80%	94.06%

In the current month, the average price target of MediWound stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to MediWound's last price of $16.49. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Oct 11, 2024	H.C. Wainwright	Buy	Buy	Hold
Sep 17, 2024	Cowen & Co.	Buy	Buy	Hold
Aug 05, 2024	Cowen & Co.	Buy	Buy	Hold
May 29, 2024	Oppenheimer	Outperform	Outperform	Hold
Dec 30, 2022	Cowen & Co.	Outperform	Outperform	Hold
Dec 22, 2022	Maxim Group		Buy	Initialise
Dec 21, 2022	Oppenheimer	Outperform	Outperform	Hold

MediWound's last stock rating was published by H.C. Wainwright on Oct 11, 2024. The company gave MDWD a "Buy" rating, the same as its previous rate.

MediWound Financial Forecast

MediWound Revenue Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$3.80M	$11.62M	$5.80M	$4.67M	$4.41M	$5.49M	$6.37M	$6.06M	$5.85M	$6.67M	$6.63M
Avg Forecast	$21.81M	$21.00M	$19.38M	$18.58M	$9.11M	$8.58M	$7.29M	$6.32M	$8.08M	$6.66M	$5.88M	$5.47M	$5.83M	$6.00M	$5.05M	$4.68M	$5.33M	$4.75M	$4.18M	$5.16M	$6.60M	$4.60M	$5.28M	$4.29M	$5.54M	$5.67M	$5.63M	$5.43M	$5.60M	$5.79M
High Forecast	$24.14M	$23.24M	$21.45M	$20.56M	$10.08M	$9.49M	$8.07M	$6.99M	$8.94M	$7.37M	$6.51M	$6.11M	$6.49M	$6.64M	$5.05M	$4.68M	$5.77M	$4.75M	$4.63M	$5.71M	$7.31M	$4.60M	$5.28M	$4.29M	$5.54M	$5.67M	$5.63M	$5.43M	$5.60M	$5.79M
Low Forecast	$20.19M	$19.44M	$17.95M	$17.20M	$8.44M	$7.94M	$6.75M	$5.85M	$7.48M	$6.17M	$5.45M	$5.10M	$5.44M	$5.56M	$5.05M	$4.68M	$4.60M	$4.74M	$3.87M	$4.78M	$6.11M	$4.60M	$5.28M	$4.29M	$5.54M	$5.67M	$5.63M	$5.43M	$5.60M	$5.79M
# Analysts	1	1	1	1	1	1	1	1	1	1	1	2	4	2	2	2	4	2	2	2	1	1	1	1	2	2	2	2	5	4
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.74%	1.76%	1.26%	0.88%	1.03%	0.99%	1.12%	1.08%	1.08%	1.19%	1.14%

MediWound's average Quarter revenue forecast for Jun 23 based on 2 analysts is $4.18M, with a low forecast of $3.87M, and a high forecast of $4.63M. MDWD's average Quarter revenue forecast represents a 10.03% increase compared to the company's last Quarter revenue of $3.80M (Mar 23).

MediWound EBITDA Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
# Analysts	1	1	1	1	1	1	1	1	1	1	1	2	4	2	2	2	4	2	2	2	1	1	1	1	2	2	2	2	5	4
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$-4.06M	$-8.77M	$-3.17M	$-3.33M	$-2.96M	$-4.64M	$-2.55M	$-2.46M	$-1.64M	$-1.77M	$-1.13M
Avg Forecast	$-7.26M	$-6.99M	$-6.46M	$-6.19M	$-3.03M	$-2.86M	$-2.43M	$-2.10M	$-2.69M	$-2.22M	$-1.96M	$-1.82M	$-1.94M	$-2.00M	$-1.68M	$-4.31M	$-1.77M	$-1.58M	$-1.39M	$-3.41M	$-2.17M	$-1.57M	$-1.81M	$-2.69M	$-1.89M	$-1.94M	$-1.93M	$-1.79M	$-1.92M	$-1.98M
High Forecast	$-6.72M	$-6.48M	$-5.98M	$-5.73M	$-2.81M	$-2.64M	$-2.25M	$-1.95M	$-2.49M	$-2.05M	$-1.81M	$-1.70M	$-1.81M	$-1.85M	$-1.68M	$-3.45M	$-1.53M	$-1.58M	$-1.29M	$-2.73M	$-1.73M	$-1.57M	$-1.81M	$-2.15M	$-1.89M	$-1.94M	$-1.93M	$-1.43M	$-1.92M	$-1.98M
Low Forecast	$-8.04M	$-7.74M	$-7.15M	$-6.85M	$-3.36M	$-3.16M	$-2.69M	$-2.33M	$-2.98M	$-2.45M	$-2.17M	$-2.04M	$-2.16M	$-2.21M	$-1.68M	$-5.17M	$-1.92M	$-1.58M	$-1.54M	$-4.09M	$-2.60M	$-1.57M	$-1.81M	$-3.23M	$-1.89M	$-1.94M	$-1.93M	$-2.14M	$-1.92M	$-1.98M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.19%	4.05%	2.01%	1.85%	1.10%	2.45%	1.31%	1.28%	0.92%	0.92%	0.57%

undefined analysts predict MDWD's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than MediWound's previous annual EBITDA (undefined) of $NaN.

MediWound Net Income Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
# Analysts	1	1	1	1	1	1	1	1	1	1	1	2	4	2	2	2	4	2	2	2	1	1	1	1	2	2	2	2	5	4
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$-3.69M	$-7.46M	$-4.20M	$-4.35M	$-3.59M	$-4.16M	$-3.35M	$-3.19M	$-3.78M	$-1.07M	$-2.35M
Avg Forecast	-	-	-	-	-	-	-	-	$-7.46M	$-6.99M	$-6.52M	$-5.83M	$-5.81M	$-5.01M	$-4.41M	$-5.22M	$-2.76M	$-4.65M	$-4.31M	$-4.13M	$-2.12M	$-6.50M	$-6.28M	$-3.26M	$-9.72M	$-8.35M	$-7.25M	$-3.11M	$-7.32M	$-6.24M
High Forecast	-	-	-	-	-	-	-	-	$-6.74M	$-6.32M	$-5.89M	$-5.40M	$-5.28M	$-4.53M	$-3.99M	$-4.18M	$839.76K	$-4.20M	$-3.89M	$-3.30M	$-1.70M	$-6.50M	$-6.28M	$-2.61M	$-9.72M	$-8.35M	$-7.25M	$-2.49M	$-7.32M	$-6.24M
Low Forecast	-	-	-	-	-	-	-	-	$-8.50M	$-7.96M	$-7.42M	$-6.05M	$-6.65M	$-5.71M	$-5.03M	$-6.27M	$-4.80M	$-5.30M	$-4.91M	$-4.95M	$-2.54M	$-6.50M	$-6.28M	$-3.92M	$-9.72M	$-8.35M	$-7.25M	$-3.73M	$-7.32M	$-6.24M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.89%	3.52%	0.65%	0.69%	1.10%	0.43%	0.40%	0.44%	1.22%	0.15%	0.38%

MediWound's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. MDWD's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

MediWound SG&A Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
# Analysts	1	1	1	1	1	1	1	1	1	1	1	2	4	2	2	2	4	2	2	2	1	1	1	1	2	2	2	2	5	4
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$3.09M	$2.69M	$3.06M	$2.29M	$2.34M	$2.36M	$2.44M	$2.60M	$2.10M	$2.38M	$2.17M
Avg Forecast	$9.17M	$8.83M	$8.15M	$7.81M	$3.83M	$3.61M	$3.06M	$2.66M	$3.40M	$2.80M	$2.47M	$2.30M	$2.45M	$2.52M	$2.12M	$3.40M	$2.24M	$1.99M	$1.76M	$2.69M	$3.05M	$1.93M	$2.22M	$2.12M	$2.33M	$2.38M	$2.37M	$2.29M	$2.35M	$2.44M
High Forecast	$10.15M	$9.77M	$9.02M	$8.64M	$4.24M	$3.99M	$3.39M	$2.94M	$3.76M	$3.10M	$2.74M	$2.57M	$2.73M	$2.79M	$2.12M	$4.08M	$2.43M	$2.00M	$1.95M	$3.22M	$3.66M	$1.93M	$2.22M	$2.55M	$2.33M	$2.38M	$2.37M	$2.74M	$2.35M	$2.44M
Low Forecast	$8.49M	$8.17M	$7.54M	$7.23M	$3.55M	$3.34M	$2.84M	$2.46M	$3.15M	$2.59M	$2.29M	$2.14M	$2.29M	$2.34M	$2.12M	$2.72M	$1.93M	$1.99M	$1.63M	$2.15M	$2.44M	$1.93M	$2.22M	$1.70M	$2.33M	$2.38M	$2.37M	$1.83M	$2.35M	$2.44M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.15%	0.88%	1.58%	1.03%	1.10%	1.01%	1.03%	1.10%	0.92%	1.01%	0.89%

MediWound's average Quarter SG&A projection for Jun 23 is $1.76M, based on 2 Wall Street analysts, with a range of $1.63M to $1.95M. The forecast indicates a -43.10% fall compared to MDWD last annual SG&A of $3.09M (Mar 23).

MediWound EPS Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
# Analysts	1	1	1	1	1	1	1	1	1	1	1	2	4	2	2	2	4	2	2	2	1	1	1	1	2	2	2	2	5	4
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$-0.44	$-1.18	$-0.88	$-0.92	$-0.87	$-0.02	$-0.84	$-0.84	$-0.70	$-0.42	$-0.49
Avg Forecast	-	-	-	-	-	-	-	-	$-0.71	$-0.67	$-0.62	$-0.56	$-0.55	$-0.48	$-0.42	$-0.41	$-0.26	$-0.44	$-0.41	$-0.30	$-0.31	$-0.70	$-0.68	$-0.76	$-1.05	$-0.90	$-0.78	$-0.78	$-0.79	$-0.67
High Forecast	-	-	-	-	-	-	-	-	$-0.64	$-0.60	$-0.56	$-0.51	$-0.50	$-0.43	$-0.38	$-0.37	$0.08	$-0.40	$-0.37	$-0.28	$-0.28	$-0.70	$-0.68	$-0.76	$-1.05	$-0.90	$-0.78	$-0.78	$-0.79	$-0.67
Low Forecast	-	-	-	-	-	-	-	-	$-0.81	$-0.76	$-0.71	$-0.58	$-0.63	$-0.54	$-0.48	$-0.46	$-0.46	$-0.50	$-0.47	$-0.35	$-0.36	$-0.70	$-0.68	$-0.76	$-1.05	$-0.90	$-0.78	$-0.78	$-0.79	$-0.67
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.44%	3.78%	1.26%	1.36%	1.15%	0.02%	0.93%	1.07%	0.90%	0.53%	0.73%

According to undefined Wall Street analysts, MediWound's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to MDWD previous annual EPS of $NaN (undefined).

MediWound Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
NKTX	Nkarta	$2.27	$21.60	851.54%	Buy
STRO	Sutro Biopharma	$2.09	$13.00	522.01%	Buy
KROS	Keros Therapeutics	$18.00	$102.00	466.67%	Buy
AVTE	Aerovate Therapeutics	$2.56	$13.00	407.81%	Hold
SANA	Sana Bio	$1.91	$8.00	318.85%	Buy
FHTX	Foghorn Therapeutics	$5.51	$14.00	154.08%	Buy
MLYS	Mineralys Therapeutics	$12.35	$30.00	142.91%	Buy
SNDX	Syndax Pharmaceuticals	$13.63	$31.67	132.36%	Buy
SWTX	SpringWorks Therapeutics	$37.72	$76.00	101.48%	Buy
MRUS	Merus	$44.90	$81.25	80.96%	Buy
RNA	Avidity Biosciences	$32.74	$59.00	80.21%	Buy
OCUL	Ocular Therapeutix	$9.02	$16.00	77.38%	Buy
MDWD	MediWound	$17.27	$28.00	62.13%	Buy
REPL	Replimune Group	$11.72	$19.00	62.12%	Buy
LYEL	Lyell Immunopharma	$0.65	$1.00	53.85%	Hold
CRNX	Crinetics Pharmaceuticals	$55.37	$69.00	24.62%	Buy
KRON	Kronos Bio	$0.96	$1.00	4.17%	Buy
VCYT	Veracyte	$42.24	$35.00	-17.14%	Buy

MDWD Forecast FAQ

Is MediWound a good buy?

Yes, according to 4 Wall Street analysts, MediWound (MDWD) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 4 'Buy' recommendations, accounting for 100.00% of MDWD's total ratings.

What is MDWD's price target?

MediWound (MDWD) average price target is $28 with a range of $28 to $28, implying a 69.80% from its last price of $16.49. The data is based on 4 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will MediWound stock go up soon?

According to Wall Street analysts' prediction for MDWD stock, the company can go up by 69.80% (from the last price of $16.49 to the average price target of $28), up by 69.80% based on the highest stock price target, and up by 69.80% based on the lowest stock price target.

Can MediWound stock reach $20?

MDWD's average twelve months analyst stock price target of $28 supports the claim that MediWound can reach $20 in the near future.

What are MediWound's analysts' financial forecasts?

MediWound's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $31.29M (high $34.64M, low $28.98M), average EBITDA is $-10.421M (high $-9.65M, low $-11.535M), average net income is $0 (high $0, low $0), average SG&A $13.15M (high $14.56M, low $12.18M), and average EPS is $0 (high $0, low $0). MDWD's analysts financial forecasts for the fiscal year (Dec 2027) are as follows: average revenue is $80.76M (high $89.4M, low $74.78M), average EBITDA is $-26.896M (high $-24.905M, low $-29.771M), average net income is $0 (high $0, low $0), average SG&A $33.95M (high $37.58M, low $31.44M), and average EPS is $0 (high $0, low $0).

Did the MDWD's actual financial results beat the analysts' financial forecasts?

Based on MediWound's last annual report (Dec 2022), the company's revenue was $26.5M, beating the average analysts forecast of $20.77M by 27.55%. Apple's EBITDA was $-9.331M, beating the average prediction of $-8.239M by 13.25%. The company's net income was $-19.599M, beating the average estimation of $-18.157M by 7.94%. Apple's SG&A was $10.37M, beating the average forecast of $9.32M by 11.24%. Lastly, the company's EPS was $-3.93, beating the average prediction of $-2.445 by 60.73%. In terms of the last quarterly report (Mar 2023), MediWound's revenue was $3.8M, missing the average analysts' forecast of $5.16M by -26.38%. The company's EBITDA was $-4.061M, beating the average prediction of $-3.407M by 19.18%. MediWound's net income was $-3.693M, missing the average estimation of $-4.127M by -10.52%. The company's SG&A was $3.09M, beating the average forecast of $2.69M by 14.95%. Lastly, the company's EPS was $-0.44, beating the average prediction of $-0.305 by 44.26%